Lapachone Completed Phase 1 Trials for Carcinoma NOS Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT00099190ARQ 501 in Combination With Docetaxel in Patients With Cancer